InvisiShield Technologies

InvisiShield Technologies is a preclinical-stage biotechnology company focused on developing intranasal preventive medications to prevent the transmission of COVID-19 in current and future potential SARS-CoV-2 variants using our proprietary "capture and kill" technology. Our proprietary technology platform can also be applied to other respiratory viruses, including influenza and RSV.